Goodman Advisory Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Goodman Advisory Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$946	Buy	+6	New	+$947	﹤0.01%	162
2026 Q2	–	Sell	-6	Closed	-$766	–	179
2026 Q1	$766	Hold	6	–	–	﹤0.01%	178
2025 Q4	$732	Hold	6	–	–	﹤0.01%	180
2025 Q3	$601	Hold	6	–	–	﹤0.01%	180
2025 Q2	$498	Hold	6	–	–	﹤0.01%	143
2025 Q1	$487	Buy	+6	New	+$536	﹤0.01%	177
2024 Q4	–	Sell	-6	Closed	-$593	–	189
2024 Q3	$593	Hold	6	–	–	﹤0.01%	191
2024 Q2	$556	Sell	6 -7	-54%	-$628	﹤0.01%	172
2024 Q1	$1.23K	Hold	13	–	–	﹤0.01%	160
2023 Q4	$1.16K	Hold	13	–	–	﹤0.01%	143
2023 Q3	$949	Hold	13	–	–	﹤0.01%	147
2023 Q2	$1.08K	Hold	13	–	–	﹤0.01%	145
2023 Q1	$991	Hold	13	–	–	﹤0.01%	148
2022 Q4	$1K	Hold	13	–	–	﹤0.01%	140
2022 Q3	$1K	Hold	13	–	–	﹤0.01%	157
2022 Q2	$1K	Buy	+13	New	+$976	﹤0.01%	169

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return

Goodman Advisory Group's XBI Position: Q3 2026 in Review

Goodman Advisory Group opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 6 shares worth $946. The stake represents ﹤0.01% of the portfolio and ranks #162 among its holdings. This is a return to the name: Goodman Advisory Group previously reported a position in XBI as recently as Q1 2026.

Goodman Advisory Group first reported a position in XBI in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.23K in Q1 2024. 714 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

Goodman Advisory Group held 6 shares of State Street SPDR S&P Biotech ETF worth $946 as of Q3 2026.
State Street SPDR S&P Biotech ETF was a new Goodman Advisory Group position in Q3 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Goodman Advisory Group's portfolio in Q3 2026, its #162 holding.
Goodman Advisory Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and has held it in 16 quarters since.
Goodman Advisory Group's State Street SPDR S&P Biotech ETF position peaked at $1.23K in Q1 2024.
714 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Goodman Advisory Group's 13F filing for Q3 2026, filed 2 Nov 2026.